← 返回

运动能否通过调节抗肿瘤免疫来增强检查点抑制的疗效?

英文原题:Can Exercise Enhance the Efficacy of Checkpoint Inhibition by Modulating Anti-Tumor Immunity?

查看英文原题

Can Exercise Enhance the Efficacy of Checkpoint Inhibition by Modulating Anti-Tumor Immunity?

PubMed 2023/09/21(内容时间) Cancers (Basel) Q2 · IF 4.8(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

免疫检查点抑制(ICI)已经彻底改变了癌症治疗。然而,对ICI的应答往往仅限于部分患者亚群,或者不能持久。对检查点抑制无应答的肿瘤其特征为抗肿瘤免疫细胞浸润低以及高度免疫抑制的肿瘤微环境。已知运动可促进免疫细胞循环并改善免疫监视。近期研究结果表明,体力活动可诱导免疫细胞向肿瘤微环境(TME)的动员和重新分布,因此增强抗肿瘤免疫。这提示运动对ICI疗效具有有利影响。我们的综述深入探讨了肌肉、肿瘤和免疫细胞之间相互作用可能的分子机制。它总结了目前关于运动诱导的抗肿瘤免疫和ICI效应在小鼠和人类中的数据。我们考虑了临床前和临床研究设计中的挑战,并讨论了癌症类型、运动频率、强度、时间和类型(FITT)以及免疫敏感性作为运动诱导对癌症免疫监视影响的关键因素的作用。

展开英文摘要原文

Immune checkpoint inhibition (ICI) has revolutionized cancer therapy.

However, response to ICI is often limited to selected subsets of patients or not durable. Tumors that are non-responsive to checkpoint inhibition are characterized by low anti-tumoral immune cell infiltration and a highly immunosuppressive tumor microenvironment. Exercise is known to promote immune cell circulation and improve immunosurveillance.

Results of recent studies indicate that physical activity can induce mobilization and redistribution of immune cells towards the tumor microenvironment (TME) and therefore enhance anti-tumor immunity. This suggests a favorable impact of exercise on the efficacy of ICI.

Our review delivers insight into possible molecular mechanisms of the crosstalk between muscle, tumor, and immune cells. It summarizes current data on exercise-induced effects on anti-tumor immunity and ICI in mice and men.

We consider preclinical and clinical study design challenges and discuss the role of cancer type, exercise frequency, intensity, time, and type (FITT) and immune sensitivity as critical factors for exercise-induced impact on cancer immunosurveillance.

论文信息

作者
Brummer C、Pukrop T、Wiskemann J、Bruss C、Ugele I、Renner K
第一作者单位
Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, 93053 Regensburg, Germany.Germany
通讯作者单位
Comprehensive Cancer Center Ostbayern (CCCO), 93053 Regensburg, Germany.Germany
文献类型
综述
期刊
Cancers2023 Sep 21
原文标识
PubMed 37760634 · DOI 10.3390/cancers15184668